Annual Long Term Debt
$12.51 B
+$9.46 B+310.49%
December 31, 2024
Summary
- As of March 8, 2025, NVO annual long term debt is $12.51 billion, with the most recent change of +$9.46 billion (+310.49%) on December 31, 2024.
- During the last 3 years, NVO annual long term debt has risen by +$10.54 billion (+534.07%).
- NVO annual long term debt is now at all-time high.
Performance
NVO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$12.51 B
+$4.80 B+62.34%
December 31, 2024
Summary
- As of March 8, 2025, NVO quarterly long term debt is $12.51 billion, with the most recent change of +$4.80 billion (+62.34%) on December 31, 2024.
- Over the past year, NVO quarterly long term debt has increased by +$5.10 billion (+68.88%).
- NVO quarterly long term debt is now at all-time high.
Performance
NVO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
NVO Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +310.5% | +68.9% |
| 3 y3 years | +534.1% | +534.1% |
| 5 y5 years | +2673.4% | +2673.4% |
NVO Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +534.1% | at high | +534.1% |
| 5 y | 5-year | at high | +2673.4% | at high | +2932.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Novo Nordisk A/S Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $12.51 B(+310.5%) | $12.51 B(+62.3%) |
| Sep 2024 | - | $7.71 B(+4.0%) |
| Jun 2024 | - | $7.41 B(+205.5%) |
| Mar 2024 | - | $2.42 B(-20.4%) |
| Dec 2023 | $3.05 B(-12.9%) | $3.05 B(+8.0%) |
| Sep 2023 | - | $2.82 B(-0.4%) |
| Jun 2023 | - | $2.83 B(-20.2%) |
| Mar 2023 | - | $3.55 B(+1.5%) |
| Dec 2022 | $3.50 B(+77.4%) | $3.50 B(+9.7%) |
| Sep 2022 | - | $3.19 B(-6.0%) |
| Jun 2022 | - | $3.39 B(-6.1%) |
| Mar 2022 | - | $3.61 B(+83.2%) |
| Dec 2021 | $1.97 B(+312.1%) | $1.97 B(+2.0%) |
| Sep 2021 | - | $1.93 B(-3.0%) |
| Jun 2021 | - | $1.99 B(+346.8%) |
| Mar 2021 | - | $446.37 M(-6.8%) |
| Dec 2020 | $478.83 M(+6.1%) | $478.83 M(+15.2%) |
| Sep 2020 | - | $415.63 M(+0.7%) |
| Jun 2020 | - | $412.59 M(-2.5%) |
| Mar 2020 | - | $423.27 M(-6.2%) |
| Dec 2019 | $451.12 M(+415.7%) | $451.12 M(+5.2%) |
| Sep 2019 | - | $428.92 M(-5.4%) |
| Jun 2019 | - | $453.53 M(-5.8%) |
| Mar 2019 | - | $481.50 M(+452.8%) |
| Sep 2012 | - | $87.09 M(+3.7%) |
| Jun 2012 | - | $84.01 M(-8.1%) |
| Mar 2012 | - | $91.44 M(+4.5%) |
| Dec 2011 | $87.48 M(-2.7%) | $87.48 M(-4.5%) |
| Sep 2011 | - | $91.62 M(-6.3%) |
| Jun 2011 | - | $97.81 M(+2.5%) |
| Mar 2011 | - | $95.40 M(+6.1%) |
| Dec 2010 | $89.91 M(-51.8%) | $89.91 M(-50.6%) |
| Sep 2010 | - | $181.89 M(+8.8%) |
| Jun 2010 | - | $167.10 M(-4.8%) |
| Mar 2010 | - | $175.60 M(-5.9%) |
| Dec 2009 | $186.57 M(+1.0%) | $186.57 M(-1.5%) |
| Sep 2009 | - | $189.47 M(+2.7%) |
| Jun 2009 | - | $184.52 M(+2.8%) |
| Mar 2009 | - | $179.55 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $184.70 M(-1.8%) | $184.70 M(+0.4%) |
| Sep 2008 | - | $184.04 M(-6.2%) |
| Jun 2008 | - | $196.11 M(-0.2%) |
| Mar 2008 | - | $196.46 M(+4.5%) |
| Dec 2007 | $188.02 M(-9.6%) | $188.02 M(-13.3%) |
| Sep 2007 | - | $216.88 M(+2.8%) |
| Jun 2007 | - | $211.00 M(+0.5%) |
| Mar 2007 | - | $210.00 M(+1.0%) |
| Dec 2006 | $207.88 M(+5.0%) | $207.88 M(+3.4%) |
| Sep 2006 | - | $201.00 M(-0.4%) |
| Jun 2006 | - | $201.83 M(+2.0%) |
| Mar 2006 | - | $197.78 M(-0.1%) |
| Dec 2005 | $198.00 M(-9.1%) | $198.00 M(-3.4%) |
| Sep 2005 | - | $204.89 M(-0.4%) |
| Jun 2005 | - | $205.70 M(-5.3%) |
| Mar 2005 | - | $217.12 M(-0.3%) |
| Dec 2004 | $217.79 M(+70.1%) | $217.79 M(+74.2%) |
| Sep 2004 | - | $125.03 M(+7.0%) |
| Jun 2004 | - | $116.87 M(-7.9%) |
| Mar 2004 | - | $126.92 M(-0.9%) |
| Dec 2003 | $128.00 M(+10.4%) | $128.00 M(+10.4%) |
| Dec 2002 | $115.90 M(+13.7%) | $115.90 M(+13.7%) |
| Dec 2001 | $101.97 M(-13.6%) | $101.97 M(-13.6%) |
| Dec 2000 | $118.01 M(-13.0%) | $118.01 M(-13.0%) |
| Dec 1999 | $135.70 M(-52.8%) | $135.70 M(-52.8%) |
| Dec 1998 | $287.31 M(+11.1%) | $287.31 M(+11.1%) |
| Dec 1997 | $258.61 M(+62.5%) | $258.61 M(+62.5%) |
| Dec 1996 | $159.17 M(-33.1%) | $159.17 M(-33.1%) |
| Dec 1995 | $238.01 M(-53.4%) | $238.01 M(-53.4%) |
| Dec 1994 | $510.82 M(+3.4%) | $510.82 M(+3.4%) |
| Dec 1993 | $493.92 M(+19.4%) | $493.92 M(+19.4%) |
| Dec 1992 | $413.52 M(+42.7%) | $413.52 M(+42.7%) |
| Dec 1991 | $289.81 M(+46.9%) | $289.81 M(+46.9%) |
| Dec 1990 | $197.30 M(-16.5%) | $197.30 M(-16.5%) |
| Dec 1989 | $236.42 M(+93.4%) | $236.42 M(+93.4%) |
| Dec 1988 | $122.26 M(-15.2%) | $122.26 M(-15.2%) |
| Dec 1987 | $144.25 M(+15.2%) | $144.25 M(+15.2%) |
| Dec 1986 | $125.17 M(+52.4%) | $125.17 M(+52.4%) |
| Dec 1985 | $82.15 M(+62.7%) | $82.15 M(+62.7%) |
| Dec 1984 | $50.48 M | $50.48 M |
FAQ
- What is Novo Nordisk A/S annual long term debt?
- What is the all time high annual long term debt for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual long term debt year-on-year change?
- What is Novo Nordisk A/S quarterly long term debt?
- What is the all time high quarterly long term debt for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly long term debt year-on-year change?
What is Novo Nordisk A/S annual long term debt?
The current annual long term debt of NVO is $12.51 B
What is the all time high annual long term debt for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual long term debt is $12.51 B
What is Novo Nordisk A/S annual long term debt year-on-year change?
Over the past year, NVO annual long term debt has changed by +$9.46 B (+310.49%)
What is Novo Nordisk A/S quarterly long term debt?
The current quarterly long term debt of NVO is $12.51 B
What is the all time high quarterly long term debt for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly long term debt is $12.51 B
What is Novo Nordisk A/S quarterly long term debt year-on-year change?
Over the past year, NVO quarterly long term debt has changed by +$5.10 B (+68.88%)